Antibody persistence and Haemophilus influenzae type b carriage after infant immunisation with PRP-T

Archives of Disease in Childhood

Volumn 77, Issue 6, 1997, Pages 488-492

  Heath, P T ^a   Bowen Morris, J ^a   Griffiths, D ^a   Griffiths, H ^a   Crook, D W M ^a   Moxon, E R ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Carriage; Conjugate vaccine; Haemophilus influenzae type b; Immunity

Indexed keywords

BACTERIAL POLYSACCHARIDE; BACTERIUM ANTIBODY; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; POLYRIBOSYLRIBITOL PHOSPHATE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; BACTERIAL INFECTION; CHILD; CLINICAL TRIAL; DISEASE CARRIER; DRUG CONJUGATION; DRUG FORMULATION; FAMILY; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; IMMUNIZATION; IMMUNOLOGICAL MEMORY; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; THROAT CULTURE;

EID: 0031457271     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.77.6.488     Document Type: Article

References (21)

1. Salisbury DM, Begg NT, eds. Immunisation schedule. 1996 Immunisation against infectious disease. London: HMSO, 1996:45-7.
2. Booy R, Hodgson SA, Slack MPE, Anderson EC, Mayon-White RT, Moxon ER. Invasive Haemophilus influenzae type b disease in the Oxford region (1985-91) Arch Dis Child 1993;69:225-8.
3. Fothergill LD, Wright J. Influenzal meningitis: the relation of age incidence to the bactericidal power of blood against the causal organism. J Immunol 1933;24:273-84.
4. Robbins JB, Park JC, Schneerson R, Whisant JK. Quantitative measurement of 'natural' and immunisation-induced Haemophilus influenzae type b capsular polysaccharide antibodies. Pediatr Res 1973;7:103-10.
5. Takala AK, Eskola J, Leinonen M, et al. Reduction of oropharyngeal carriage of the Haemophilus influenzae type b (Hib) in children immunised with a Hib conjugate vaccine. J Infect Dis 1991; 164:982-6.
6. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Surveillance of vaccine failures following primary immunisation of infants with Hib conjugate vaccine: evidence for protection without boosting. Lancet 1997;349:1197-202.
7. Kayhty H, Peltola H, Karanko V, Makela PH. The protective level of serum antibodies to the capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100.
8. Booy R, Taylor SA, Dobson SRM, et al. Immunogenicity and safety of PRP-T conjugate vaccine given according to the British accelerated immunisation schedule. Arch Dis Child 1992;67:475-8.
9. Kayhty H, Eskola J, Peltola H, Saarinen L, Makela PH. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunisation with conjugate vaccines. J Infect Dis 1992;165(suppl 1):165-6.
10. Makela PH, Peltola H, Kayhty H, et al. Polysaccharide vaccines of group A Neisseria meningitidis and Haemophilus influenzae type b: a field trial in Finland. J Infect Dis 1977; 136(suppl):S43-50.
11. Falla TJ, Crook DWM, Brophy LN, Maskell D, Kroll JS, Moxon ER. Polymerase chain reaction for capsular typing of Haemophilus influenzae. J Clin Microbiol 1994;32:2382-6.
12. Barbour ML, Booy R, Crook DWM, et al. Haemophilus influenzae type b carriage and immunity 4 years after receiving the oligosaccharide-CRM 197 (HbOC) conjugate vaccine. Pediatr Infect Dis J 1993;12:478-84.
13. Santosham M, Wolff M, Reid R, et al. The efficacy in Navajo infants of a conjugate vaccine consisting of Haemophilus influenzae type b polysaccharide and Neisseria meningitidis outer-membrane protein complex. N Engl J Med 1991;324:1767-72.
14. Booy R, Hodgson S, Griffiths H, Chapel HM, Moxon ER. Antibody persistence after accelerated immunisation against Haemophilus influenzae type b. BMJ 1993;306: 971-2.
15. Weinberg GA, Einhorn MS, Lenoir AA, Granoff PD, Granoff DM. Immunological priming to capsular polysaccharide in infants immunized with Haemophilus influenzae type b polysaccharide - Neisseria meningitidis outer-membrane protein conjugate vaccine. J Pediatr 1987;111: 22-7.
16. Eskola J, Kayhty H. Ten years experience with Haemophilus influenzae type b (Hib) conjugate vaccines in Finland. Reviews in Medical Microbiology 1996;7:231-41.
17. r). The Icelandic Medical Journal 1996; 82:32-8.
18. Claesson BA, Trollfors B, Anderson PW, et al. Serum antibodies in 6 year old children vaccinated in infancy with a Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. Pediatr Infect Dis J 1996;15:170-1.
19. Mohle-Boetani J, Ajello G, Brenenan E, et al. Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J 1993;12:589-93.
20. Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The impact of conjugate vaccine on carriage on Haemophilus influenzae type b. J Infect Dis 1995;171: 93-8.
21. Robbins JB, Schneerson R, Glode MP, et al. Cross reactive antigens and immunity to diseases caused by encapsulated bacteria. J Allergy Clin Immunol 1975;56:141-51.